3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
4
Endocrine
4
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
CNS
1
Conditions
Solid Tumors
4
Advanced Solid Tumors
4
Solid Tumor
3
Mesothelioma
3
Advanced Solid Tumor
3
Advanced Solid Tumours
2
Thymoma
1
Neuroendocrine Tumors
1
Mesothelioma, Malignant
1
Malignant Solid Tumors
1
Lung Neoplasms
1
Advanced Solid Tumor, Adult
1
Advanced Cancer
1
Interventions
pembrolizumab
1
olaparib
1
fludarabine phosphate
1
fludarabine
1
Quality of Life
1
Patient Reported Outcome Measures
1
PM 01183
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Irinotecan
1
Immunotherapy
1
Drug Therapy
1
Cyclophosphamide
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroendocrine Tumors
×
olaparib
×
Other solid neoplasm
×
Clear all
NCT04375267
2026-04-14
LuPARP
Vastra Gotaland Region
Phase 1
Completed
18 enrolled